Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
| Mail converted by MHonArc 2.6.10 |
|
Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
NEWS: GDNF: Gene Therapy Protects Dopaminergic Neurons
| Mail converted by MHonArc 2.6.10 |
|
------------------------------------------------------------------------ GDNF Gene Therapy Protects Dopaminergic Neurons ------------------------------------------------------------------------ WESTPORT, Feb 07 (Reuters) - In rats, glial-derived neurotrophic factor (GDNF) gene therapy ameliorates the effect of experimentally induced degeneration of dopaminergic neurons, pointing to a hopeful new approach to treating Parkinson's disease. Dr. Martha Bohn of the University of Rochester, Rochester, New York, describes the findings in the journal Science today: "[GDNF] supports growth and survival of dopaminergic (DA) neurons. A replication-defective adenoviral (Ad) vector encoding human GDNF injected near the rat substantia nigra was found to protect DA neurons from the progressive degeneration induced by [a] neurotoxin...injected into the striatum." GDNF-treated rats had roughly a three-fold reduction in neuronal loss compared with untreated rats. "It is not known how closely neurotoxin-induced lesions mimic the state of diseased neurons in humans with Parkinson's' disease," Dr. Bohn notes. "The mechanism of [dopaminergic] neuronal loss in Parkinson's disease is unknown... [however] GDNF gene therapy is likely to protect diseased human neurons, regardless of the mechanism of degeneration involved." Dr. Gene Redmond of Yale comments in University press release: "There has been a great deal of work suggesting that GDNF might be useful in the brain; the critical limiting factor has been the lack of an appropriate long-lasting method of delivery. Packaging GDNF in a viral vector and inserting it directly into brain cells is quite ingenious." Science 1997;275:838-841. Westport Newsroom 203 221 7648 Copyright 1997 Reuters Limited. <http://www.reutershealth.com/news/docs/199702/19970207sca.html> ------------------------------------------------------------------------ ----------janet-paterson---50-9---paterson@xxxxxxxxxxxxxxxxxxxxxxxxxxx
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10